German Testicular Cancer Study Group Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2006
NCT00371553
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

German Testicular Cancer Study Group

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms, Germ Cell and Embryonal (Phase 2)

Seminoma (Phase 2)

Testicular Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 4